Literature DB >> 26203048

Ferric pyrophosphate: good things come to those who wait?

Lisa H Fell1, Danilo Fliser1, Gunnar H Heine1.   

Abstract

Entities:  

Year:  2015        PMID: 26203048      PMCID: PMC4832995          DOI: 10.1093/ndt/gfv287

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  16 in total

1.  Ferric citrate controls phosphorus and delivers iron in patients on dialysis.

Authors:  Julia B Lewis; Mohammed Sika; Mark J Koury; Peale Chuang; Gerald Schulman; Mark T Smith; Frederick C Whittier; Douglas R Linfert; Claude M Galphin; Balaji P Athreya; A Kaldun Kaldun Nossuli; Ingrid J Chang; Samuel S Blumenthal; John Manley; Steven Zeig; Kotagal S Kant; Juan Jose Olivero; Tom Greene; Jamie P Dwyer
Journal:  J Am Soc Nephrol       Date:  2014-07-24       Impact factor: 10.121

2.  Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study.

Authors:  Navdeep Tangri; Dana C Miskulin; Jing Zhou; Karen Bandeen-Roche; Wieneke M Michels; Patti L Ephraim; Aidan McDermott; Deidra C Crews; Julia J Scialla; Stephen M Sozio; Tariq Shafi; Bernard G Jaar; Klemens Meyer; L Ebony Boulware
Journal:  Nephrol Dial Transplant       Date:  2014-11-02       Impact factor: 5.992

3.  Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality.

Authors:  George R Bailie; Maria Larkina; David A Goodkin; Yun Li; Ronald L Pisoni; Brian Bieber; Nancy Mason; Lin Tong; Francesco Locatelli; Mark R Marshall; Masaaki Inaba; Bruce M Robinson
Journal:  Kidney Int       Date:  2014-07-30       Impact factor: 10.612

4.  Correction of anemia with epoetin alfa in chronic kidney disease.

Authors:  Ajay K Singh; Lynda Szczech; Kezhen L Tang; Huiman Barnhart; Shelly Sapp; Marsha Wolfson; Donal Reddan
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

Review 5.  Iron and vascular calcification. Is there a link?

Authors:  Ellen Neven; Tineke M De Schutter; Geert J Behets; Ajay Gupta; Patrick C D'Haese
Journal:  Nephrol Dial Transplant       Date:  2011-02-16       Impact factor: 5.992

6.  Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010).

Authors:  Wolfgang C Winkelmayer; Aya A Mitani; Benjamin A Goldstein; M Alan Brookhart; Glenn M Chertow
Journal:  JAMA Intern Med       Date:  2014-05       Impact factor: 21.873

7.  A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

Authors:  Marc A Pfeffer; Emmanuel A Burdmann; Chao-Yin Chen; Mark E Cooper; Dick de Zeeuw; Kai-Uwe Eckardt; Jan M Feyzi; Peter Ivanovich; Reshma Kewalramani; Andrew S Levey; Eldrin F Lewis; Janet B McGill; John J V McMurray; Patrick Parfrey; Hans-Henrik Parving; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert Toto
Journal:  N Engl J Med       Date:  2009-10-30       Impact factor: 91.245

Review 8.  Use of intravenous iron supplementation in chronic kidney disease: an update.

Authors:  Iain C Macdougall; Peter Geisser
Journal:  Iran J Kidney Dis       Date:  2013-01       Impact factor: 0.892

Review 9.  Iron toxicity: relevance for dialysis patients.

Authors:  Steven Fishbane; Anna Mathew; Nosratola D Vaziri
Journal:  Nephrol Dial Transplant       Date:  2013-10-28       Impact factor: 5.992

10.  Distinct immunologic effects of different intravenous iron preparations on monocytes.

Authors:  Lisa H Fell; Adam M Zawada; Kyrill S Rogacev; Sarah Seiler; Danilo Fliser; Gunnar H Heine
Journal:  Nephrol Dial Transplant       Date:  2014-02-11       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.